And it depends on you how soon it will be developed
Increasing wariness in Washington over China’s investments in U.S. biotechnology companies may cool a hot source of capital for medical startups.
Swiss drugmaker Roche is buying U.S.-based Jecure Therapeutics, joining Pfizer, Gilead Sciences and Novartis in pursuit of new drugs to treat fatty liver disease.
BIDMC Research Briefs showcase groundbreaking scientific advances that are transforming medical care.
Researchers take an ordinary white button mushroom and supercharge it with clusters of tightly-packed cyanobacteria and swirls of graphene nanoribbons to make electricity